Immunotherapy + mRNA Technology To Treat Triple Negative Breast Cancer
On this basis, the research team used LCOR mRNA in combination with PD-L1 inhibitors to completely eliminate triple-negative breast cancer cells in a mouse model and prevent cancer recurrence, achieving a complete cure.
Like this book? You can publish your book online for free in a few
minutes!